News

Bone Therapeutics Successfully Raises EUR 8.5 MILLION

Bone Therapeutics SA announces that it has successfully raised EUR 8.5 million in gross proceeds through a private placement. Thomas Lienard, Chief Executive Officer, commented: “The level of support we received from our existing and new investors is a true recognition of our potential to fundamentally change the way patients with bone diseases and orthopaedic conditions are treated".   Please discover the press release here.

Read more

Univercells granted $14.3 Million to deliver affordable measles and rubella vaccines using its NevoLine™ manufacturing platform

Univercells announces that it has been awarded a $14.3 million grant by the Bill & Melinda Gates Foundation to increase the availability of measles and rubella (M&R) vaccines in low- and middle-income countries (LMICs). Univercells will adapt the process design of its proprietary NevoLine™ platform to deliver affordable M&R vaccines.  Please discover the press release here.

Read more